Browse articles on EyeWorld.org from the Glaucoma section. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Steroid-induced glaucoma can present a number of issues, most notably increased IOP. Several ophthalmologists discussed identifying when and why this occurs and how to react to help improve the pressure.
Manjool Shah, MD, gave an overview of the articles in the Glaucoma section, noting, “The insights shared by our contributors serve as a reminder of the importance of continuous learning and adaptation, and there is no place better to feel the energy of lifelong learning like the ASCRS Annual Meeting.”
Pseudoexfoliation syndrome is a systemic, age-related disease, with patients needing more frequent monitoring due to an increased risk of developing secondary open angle glaucoma from the condition. Two physicians provided their perspectives on the condition and advice for its identification, management, and considerations for surgery.
During the COVID-19 pandemic, ophthalmic practices turned to telemedicine to stay in contact with patients and get them the care they needed. In this article, two physicians discussed their experience with telemedicine, including how they saw its applications evolve and thoughts on the future potential of telehealth options.
In his introduction to the “Interventional glaucoma” bonus issue of EyeWorld, Chief Medical Editor Sumit “Sam” Garg, MD, shared some of his personal experiences in this space and what topics readers can expect to learn more about.
Glaucoma Editor Manjool Shah, MD, provided his thoughts on the evolution of interventional glaucoma.
MIGS has continued to expand in its application for a wide variety of patients with varying degrees of glaucoma. Several physicians discussed where various MIGS procedures fit into interventional glaucoma, including applications for standalone MIGS and how it continues to play a role in conjunction with cataract surgery.
Two glaucoma specialists spoke with EyeWorld about the current role of SLT, as well as products in development and further research in the glaucoma laser space.
While glaucoma treatment is shifting toward a more interventional approach, two physicians said the use of drop therapy is alive and well. It is trending toward being an adjunctive therapy as more ophthalmologists are beginning to figure out what pharmaceutical and procedural combinations best suit their patients.
Many MIGS procedures are proving useful and accessible not just to the glaucoma specialist but to comprehensive ophthalmologists as well. Two ophthalmologists discussed who should be performing glaucoma surgery, as well as ways to learn and stay fresh with some of these techniques.
Get the latest ophthalmology news delivered to your inbox every Friday.